InvestorsHub Logo
Followers 85
Posts 314
Boards Moderated 0
Alias Born 06/20/2020

Re: rockie101 post# 54047

Monday, 12/07/2020 9:01:29 PM

Monday, December 07, 2020 9:01:29 PM

Post# of 198648
Great interview. NASDAQ Caliber CEO in the Driver's Seat.

Mr. Cotropia is A World Renowned Patent Attorney with valuable IP in the company's pipeline. They've recently formed 2 new wholly owned subsidiaries ready to license the cutting edge biotech to the highest big pharma bidder.

A lot of great information in here, including that they will be testing on patients. Confirmation that they will be working on BOTH coronavirus and HIV at Texas A&M was also big considering the manufacturing capacity at this location.

Really don't know what else to say at this point. Amazing company. Amazing Team. Amazing biotechnology. We're all witnesses.

SUPPLY AND DEMAND will rule the day.

MONOCLONAL ANTIBODY Treatments save lives and will help re-open the economy; therefore, the demand will be overwhelming when the general public catches on (needs more media attention, which I think will come).

Supply is low as Lilly and Regeneron can't produce enough.

$ENZC CEO ended the CEO with the following:

"The whole process is, in our view, a perfect approach to producing therapeutics that are safe and effective and that address and overcome the effect of virus mutation - all the while being able to be produced inexpensively, so they may be provided throughout the world."

Supply problem solved.

https://twitter.com/UncleBillyMoney/status/1336126709905690625?s=20